Search results for " PROGRESS"

showing 10 items of 1287 documents

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis

2019

\(\bf Objective:\) The autoimmune disease Multiple Sclerosis (MS) represents a heterogeneous disease pattern with an individual course that may lead to permanent disability. In addition to immuno-modulating therapies patients benefit from symptomatic approaches like intrathecal corticosteroid therapy (ICT), which is frequently applied in a growing number of centers in Germany. ICT reduces spasticity, which elongates patient's walking distance and speed, thus improves quality of life. \(\bf Methods:\) In our study we set out to investigate cerebrospinal fluid (CSF) parameters and clinical predictors for response to ICT. Therefore, we analyzed 811 CSF samples collected from 354 patients over …

disease progressionNeurologyclinical predictorparasitic diseasesintrathecal corticosteroid therapyddc:610multiple sclerosiscerebrospinal fluidlcsh:Neurology. Diseases of the nervous systemlcsh:RC346-429Original ResearchFrontiers in Neurology
researchProduct

Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.

1999

Tenascin is an extracellular matrix glycoprotein, relevant for embryonal and fetal development, which is reexpressed in the stroma of benign and malignant tumors. Little is known about the molecular interaction of tenascin during neoplastic transformation and tumor progression in cervical cancer.We studied the expression of tenascin in normal tissue of the cervix uteri, cervical carcinoma in situ, and invasive cervical carcinoma in paraffin sections by immunohistochemistry using a monoclonal antibody. Tenascin immunoreactivity was compared with various prognostic parameters.In normal cervical tissue (n = 5) and in cervical carcinoma in situ (n = 10) only vessel walls showed a weak tenascin …

endocrine systemPathologymedicine.medical_specialtyanimal structuresStromal cellConnective tissueTenascinUterine Cervical NeoplasmsMalignant transformationmedicineHumansNeoplastic transformationCervixRetrospective Studiesbiologybusiness.industryObstetrics and GynecologyTenascinmusculoskeletal systemPrognosisImmunohistochemistrySurvival Ratemedicine.anatomical_structureOncologyTumor progressionembryonic structuresbiology.proteinDisease ProgressionImmunohistochemistryFemalebusinessCarcinoma in SituGynecologic oncology
researchProduct

EZH2 mutations are frequent and represent an early event in follicular lymphoma

2013

Gain of function mutations in the H3K27 methyltransferase EZH2 represent a promising therapeutic target in germinal center lymphomas. In this study, we assessed the frequency and distribution of EZH2 mutations in a large cohort of patients with follicular lymphoma (FL) (n = 366) and performed a longitudinal analysis of mutation during the disease progression from FL to transformed FL (tFL) (n = 33). Mutations were detected at 3 recurrent mutation hot spots (Y646, A682, and A692) in 27% of FL cases with variant allele frequencies (VAF) ranging from 2% to 61%. By comparing VAF of EZH2 with other mutation targets (CREBBP, MLL2, TNFRSF14, and MEF2B), we were able to distinguish patients harbori…

endocrine systemTime FactorsMethyltransferasemedicine.medical_treatmentDNA Mutational AnalysisImmunologyFollicular lymphomaKaplan-Meier Estimatemacromolecular substancesBiologymedicine.disease_causeBiochemistryTargeted therapyCohort StudiesGene Frequencyhemic and lymphatic diseasesBiomarkers TumormedicineHumansEnhancer of Zeste Homolog 2 ProteinLymphoma FollicularAllele frequencyMutationLymphoid NeoplasiaMEF2 Transcription FactorsGene Expression ProfilingEZH2Polycomb Repressive Complex 2Germinal centerCell BiologyHematologymedicine.diseaseCREB-Binding ProteinLymphomaMutationDisease ProgressionCancer researchReceptors Tumor Necrosis Factor Member 14Blood
researchProduct

Guidelines for biomarker discovery in endometrium: correcting for menstrual cycle bias reveals new genes associated with uterine disorders

2021

Abstract Transcriptomic approaches are increasingly used in reproductive medicine to identify candidate endometrial biomarkers. However, it is known that endometrial progression in the molecular biology of the menstrual cycle is a main factor that could affect the discovery of disorder-related genes. Therefore, the aim of this study was to systematically review current practices for considering the menstrual cycle effect and to demonstrate its bias in the identification of potential biomarkers. From the 35 studies meeting the criteria, 31.43% did not register the menstrual cycle phase. We analysed the menstrual cycle effect in 11 papers (including 12 studies) from Gene Expression Omnibus: t…

endometriosisEmbryologyUterine fibroidsmedia_common.quotation_subjectmenstrual cycle progressionEndometriosisBiologyBioinformaticsEndometriumdifferential expressionEndometriumendometrial pathologiesGeneticsmedicineHumansuterine fibroidsBiomarker discoveryMolecular Biologytranscriptomic analysisMenstrual CycleMenstrual cycleOriginal Researchrecurrent implantation failuremedia_commonUterine Diseasesrecurrent pregnancy lossObstetrics and GynecologyCell Biologymedicine.diseaseAcademicSubjects/MED00905Uterine DisorderMenstrual cycle phaseconfounding variablemedicine.anatomical_structureReproductive Medicinegene expressionOvarian EndometriosisFemaleTranscriptomeDevelopmental BiologyMolecular Human Reproduction
researchProduct

Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.

2006

It is well established that cancer arises in chronically inflamed tissue, and this is particularly notable in the gastrointestinal tract. Classic examples include Helicobacter pylori-associated gastric cancer, hepatocellular carcinoma, and inflammatory bowel disease-associated colorectal cancer. Growing evidence suggests that these associations might be not casual findings. Focusing on individual cytokines has generated evidence that anti-inflammatory cytokine interleukin (IL)-10 and transforming growth factor-beta1 (TGF-beta1) may have a complex role in gastrointestinal carcinogenesis. As an example, IL-10-deficient mice develop severe atrophic gastritis and a chronic enterocolitis, develo…

gene polymorphismsMaleRiskProlineColorectal cancerAtrophic gastritisil-10colorectal cancerMouse model of colorectal and intestinal cancerBiologymedicine.disease_causePolymorphism Single NucleotideGeneral Biochemistry Genetics and Molecular BiologyMetastasisTransforming Growth Factor beta1colorectal cancercytokine genepolymorphismsHistory and Philosophy of ScienceGene FrequencyLeucineGenotypemedicineHumansGenetic Predisposition to DiseaseAllelesGeneral Neurosciencetgf-β1CarcinomaCancermedicine.diseaseInterleukin-10Amino Acid SubstitutionItalyTumor progressionCase-Control StudiesImmunologycolorectal cancer; gene polymorphisms; il-10; tgf-β1FemaleCarcinogenesisColorectal NeoplasmsAnnals of the New York Academy of Sciences
researchProduct

Time to ferry heart failure onto new shores: The need to effectively customize long-term therapy

2011

heart failure therapymedicine.medical_specialtybusiness.industryTreatment outcomeDisease progressionMEDLINEmedicine.diseaseHeart failureInternal medicinemedicineCardiologyLong term therapyCardiology and Cardiovascular MedicineIntensive care medicinebusinessAmerican Heart Journal
researchProduct

Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized …

2008

Summary Purpose A phase III randomized trial was carried out to compare two schedules of the vinorelbine (VNR)–cisplatin (CDDP) regimen in patients with locally advanced unresectable poor prognosis stage IIIB or metastatic stage IV non-small cell lung cancer. The primary endpoints were overall survival (OS) and analysis of toxicity, while secondary endpoints included response rates, time-to-progression (TTP) and quality of life (QoL). Patients and methods Eligible patients were randomized to receive: (a) VNR 25 mg/m 2 on day 1, 8 and 15 plus CDDP 100 mg/m 2 on day 1 every 4 weeks or (b) VNR 30 mg/m 2 on day 1 and 8 plus CDDP 80 mg/m 2 on day 1 every 3 weeks. All patients were chemotherapy-n…

inorganic chemicalsPulmonary and Respiratory MedicineAdultMaleCancer Researchmedicine.medical_specialtyRandomizationLung NeoplasmsVinorelbineVinblastineGastroenterologyStatistics Nonparametriclaw.inventionRandomized controlled triallawInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesLung cancerProspective cohort studyneoplasmsAgedNeoplasm StagingChi-Square Distributionbusiness.industryVinorelbineMiddle Agedmedicine.diseaseVinblastineSurgeryRegimenLogistic ModelsTreatment OutcomeOncologyItalyDisease ProgressionQuality of LifeFemaleCisplatinbusinessFebrile neutropeniamedicine.drugLung cancer (Amsterdam, Netherlands)
researchProduct

Neoclassical Growth, Environment and Technological Change: The Environmental Kuznets Curve

2009

The paper investigates socially optimal patterns of economic growth and environmental quality in a neoclassical growth model with endogenous technological progress. In the model, the environmental quality affects positively not only to utility but also to production. However, cleaner technologies can be used in the economy whether a part of the output is used in environmentally oriented R&D. In this framework, if the initial level of capital is low then the shadow price of a cleaner technology is low relative to the cost of developing it given by the marginal utility of consumption and it is not worth investing in R&D. Thus, there will be a first stage of growth based only on the accumulati…

jel:O41jel:Q55jel:O33jel:Q56Neoclassical Growth Model Endogenous Technological Progress External Effects Environmental Kuznets Curve
researchProduct

PNRR, lavoro pubblico e dintorni

2022

La legislazione di attuazione del PNRR contiene misure sul reclutamento e sulla progressione di carriera del personale pubblico, nonche´ sulla dirigenza, dirette allo scopo del rafforzamento della capacita` amministrativa delle istituzioni pubbliche. Esse presentano alcune luci e molte ombre su cui vale la pena soffermarsi. Peraltro, i grandi processi di trasformazione e transizione in atto reclamano un forte coinvolgimento delle parti sociali per garantire una loro gestione e una (auspicabile) crescita economica socialmente eque e sostenibili.

lavoro pubblico reclutamento progressioni di carrieraSettore IUS/07 - Diritto Del Lavoro
researchProduct

I valori etici e religiosi nell'economia secondo Giuseppe Toniolo

2010

Toniolo pone al centro del discorso economico l'uomo valorizzandone la dignità, la libertà, l'eguaglianza morale, la corresponsabilità e l'eticità.

lavoro progresso economico ordine socialeSettore SECS-P/04 - Storia Del Pensiero Economico
researchProduct